🇺🇸 immune-checkpoint inhibitors therapies in United States

immune-checkpoint inhibitors therapies (immune-checkpoint inhibitors therapies) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

immune-checkpoint inhibitors therapies in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is immune-checkpoint inhibitors therapies approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for immune-checkpoint inhibitors therapies in United States?

Institut Paoli-Calmettes is the originator. The local marketing authorisation holder may differ — check the official source linked above.